| Entry |
|
|---|
| Name |
Eprosartan mesylate (USAN);
Teveten (TN) |
|---|
| Formula |
C23H24N2O4S. CH4SO3
|
|---|
| Exact mass |
520.1338
|
|---|
| Mol weight |
520.6183
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive, Angiotensin II receptor antagonist |
|---|
| Disease |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07229 | Angiotensin receptor and endothelin receptor antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09CA Angiotensin II receptor blockers (ARBs), plain
C09CA02 Eprosartan
D02082 Eprosartan mesylate (USAN)
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Eprosartan
D02082 Eprosartan mesylate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00349 Eprosartan
D02082 Eprosartan mesylate
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00349 Eprosartan
D02082 Eprosartan mesylate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D02082 Eprosartan mesylate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00349 Eprosartan
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00349 Eprosartan
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 35
1 S4a S 30.8361 -23.7268
2 O1d O 30.8361 -22.3207
3 O1d O 30.8361 -25.1329
4 O1d O 32.2422 -23.7268
5 C1a C 29.4300 -23.7268
6 C8x C 17.2200 -21.0700
7 C8y C 17.2200 -22.4700
8 C8x C 18.4100 -23.2400
9 C8x C 19.6000 -22.4700
10 C8y C 19.6000 -21.0700
11 C8x C 18.4100 -20.3700
12 C1b C 20.8600 -20.3700
13 N4y N 22.0500 -21.0700
14 C8y C 22.5400 -22.4000
15 C8x C 23.9400 -22.4000
16 N5x N 24.3600 -21.0700
17 C8y C 23.2400 -20.2300
18 C6a C 15.9600 -23.2400
19 O6a O 14.7700 -22.5400
20 O6a O 15.9600 -24.6400
21 C1b C 23.2400 -18.8300
22 C1b C 24.4300 -18.1300
23 C1b C 25.6900 -18.8300
24 C1a C 26.8800 -18.1300
25 C2b C 21.8400 -23.6600
26 C2c C 22.5400 -24.8500
27 C1b C 23.9400 -24.8500
28 C6a C 21.8400 -26.0400
29 O6a O 20.4400 -26.0400
30 O6a O 22.5400 -27.2300
31 C8y C 24.6400 -26.0400
32 C8x C 24.2900 -27.3700
33 C8x C 25.4100 -28.1400
34 C8x C 26.4600 -27.3000
35 S2x S 26.0400 -25.9700
BOND 36
1 1 2 2
2 1 3 2
3 1 4 1
4 1 5 1
5 6 7 2
6 7 8 1
7 8 9 2
8 9 10 1
9 10 11 2
10 6 11 1
11 10 12 1
12 12 13 1
13 13 14 1
14 14 15 2
15 15 16 1
16 16 17 2
17 13 17 1
18 7 18 1
19 18 19 1
20 18 20 2
21 17 21 1
22 21 22 1
23 22 23 1
24 23 24 1
25 14 25 1
26 25 26 2
27 26 27 1
28 26 28 1
29 28 29 1
30 28 30 2
31 27 31 1
32 31 32 2
33 32 33 1
34 33 34 2
35 34 35 1
36 31 35 1
|
|---|
